News

Medinex - High quality treatment of oncological deceases

High quality treatment of oncological deceases

05.11.2022

News

Saniya Usabekova, Deputy Director for Development of the  "Umit” oncological  center for tomotherapy

Daulet Berikbol, oncologist-radiologist of the "Umit" oncological center for tomotherapy  (Kazakhstan)

International Oncological Center for Tomotherapy "Umit" (Astana) has a multidisciplinary clinic and an oncological center.

The exhibition presents the department of tomotherapy and diagnostics of our oncological center. The clinic has a department of chemotherapy, which makes it possible to provide oncological patients with full-cycleservices. We treat children from one and a half years old and adults without age restrictions, including those with concomitant diseases. We have signed memorandums with clinics of various profiles, which allows us to involve the specialists of other treatment fields. Our specialists have been trained in leading oncological centers of the USA, Italy, France and India.

The center is equipped with modern Tomotherapy HD, which puts less strain on healthy tissues. Among our patients are citizens of Kazakhstan, Russia and Central Asian countries. At this exhibition, we would like to show the citizens of Azerbaijan the possibility of a high-quality treatment of oncological diseases.

We are participating in Medinex for the first time and are very pleased with its progress. Emotionally, we were pleased with the attitude towards us, as citizens of a brother country. In business terms, we had interesting meetings with representatives of the Baku Oncological Center, discussed issues of cooperation and exchange of experience between the doctors and nurses of our clinics.

All over the world, the exhibition is a big, serious tool for market development and cooperation at the international level. I would like to thank the organisers of the exhibition for their active work with exhibitors. All the necessary conditions were created for us to assist with relevant organisations as well as the B2B meetingsthat should inevitably give their results. We already have plans to participate in the next year's exhibition. We discussed with the organisers the tasks and conditions that need to be solved for our more effective participation in Medinex 2023.


PARTNERS